ArticleThe Journal of allergy and clinical immunology2019
A comprehensive characterization of chronic norovirus infection in immunodeficient hosts.
Abstract readLetter
In one paragraph
Article in The Journal of allergy and clinical immunology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.
0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed.
- IgA and IgM-enriched Immunoglobulins in Primary Immunodeficiencies: a Pilot Study.Journal of clinical immunology · 2025Article
- Current infectious disease management challenges in inborn errors of immunity.Annals of clinical microbiology and antimicrobials · 2025Review
- Breast milk delivery of an engineered dimeric IgA protects neonates against rotavirus.Mucosal immunology · 2025Article
- A Decade of Chronic Norovirus Infection Surveillance at the National Institutes of Health Clinical Research Center: Clinical Characteristics, Molecular Epidemiology, and Replication.The Journal of infectious diseases · 2025Article
- Reconstitution of Norovirus-Specific T-Cell Responses Following Hematopoietic Stem Cell Transplantation in Patients With Inborn Errors of Immunity and Chronic Norovirus Infection.The Journal of infectious diseases · 2025Article
- Lipid nanoparticles as adjuvant of norovirus VLP vaccine augment cellular and humoral immune responses in a TLR9- and type I IFN-dependent pathway.Journal of virology · 2024Article
- The Scope and Impact of Viral Infections in Common Variable Immunodeficiency (CVID) and CVID-like Disorders: A Literature Review.Journal of clinical medicine · 2024Review
- Favipiravir induces HuNoV viral mutagenesis and infectivity loss with clinical improvement in immunocompromised patients.Clinical immunology (Orlando, Fla.) · 2024Article
- Norovirus Infection in Children with Acute Lymphoblastic Leukemia.Infection & chemotherapy · 2023Article
- Characterization of infectious and non-infectious gastrointestinal disease in common variable immunodeficiency: analysis of 114 patient cohort.Frontiers in immunology · 2023Article
- Article
- Bowel Histology of CVID Patients Reveals Distinct Patterns of Mucosal Inflammation.Journal of clinical immunology · 2022Article
- Review
- Review
- Update on Infections in Primary Antibody Deficiencies.Frontiers in immunology · 2021Review
- Virus-Host Interactions Between Nonsecretors and Human Norovirus.Cellular and molecular gastroenterology and hepatology · 2020Article
- Altered Microbiota, Impaired Quality of Life, Malabsorption, Infection, and Inflammation in CVID Patients With Diarrhoea.Frontiers in immunology · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
22 authors.
Li-An K BrownDepartment of Infectious Diseases, Royal Free London NHS Foundation Trust, London, United Kingdom; Department of Microbiology, Whittington Health NHS Trust, London, United Kingdom.
Christopher RuisDivision of Infection and Immunity, University College London, London, United Kingdom; Molecular Immunity Unit, Department of Medicine, University of Cambridge, Medical Research Council (MRC)-Laboratory of Molecular Biology, Cambridge, United Kingdom.
Ian ClarkDepartment of Histopathology, Royal Free London NHS Foundation Trust, London, United Kingdom.
Sunando RoyDivision of Infection and Immunity, University College London, London, United Kingdom.
Julianne R BrownDepartment of Microbiology, Virology and Infection Prevention and Control, Great Ormond Street Hospital for Children NHS Foundation Trust, London, United Kingdom.
Adriana S AlbuquerqueInstitute of Immunity and Transplantation, University College London, Royal Free Campus, London, United Kingdom.
Smita Y PatelOxford University Hospitals NHS Trust and NIHR Oxford Biomedical Research Centre, Oxford, United Kingdom.
Joanne MillerRoyal Surrey County Hospital NHS Foundation Trust, Egerton Road, Guildford, Surrey, United Kingdom.
Mohammed Yousuf KarimRoyal Surrey County Hospital NHS Foundation Trust, Egerton Road, Guildford, Surrey, United Kingdom; Pathology, Sidra Medicine, Doha, Qatar.
Samir DervisevicNorfolk and Norwich University Hospital, Norwich, Norfolk, United Kingdom.
Jennifer MooreNorfolk and Norwich University Hospital, Norwich, Norfolk, United Kingdom.
Charlotte A WilliamsDivision of Infection and Immunity, University College London, London, United Kingdom.
Juliana CudiniDivision of Infection and Immunity, University College London, London, United Kingdom.
Fernando MoreiraDepartment of Clinical Immunology, Royal Free London NHS Foundation Trust, London, United Kingdom.
Penny NeildSt George's University Hospitals NHS Foundation Trust, London, United Kingdom.
Suranjith L SeneviratneDepartment of Clinical Immunology, Royal Free London NHS Foundation Trust, London, United Kingdom.
Sarita WorkmanDepartment of Clinical Immunology, Royal Free London NHS Foundation Trust, London, United Kingdom.
Christos ToumpanakisDepartment of Gastroenterology, Royal Free London NHS Foundation Trust, London, United Kingdom.
Claire AtkinsonInstitute of Immunity and Transplantation, University College London, Royal Free Campus, London, United Kingdom.
Siobhan O BurnsInstitute of Immunity and Transplantation, University College London, Royal Free Campus, London, United Kingdom; Department of Clinical Immunology, Royal Free London NHS Foundation Trust, London, United Kingdom.
Judith BreuerDivision of Infection and Immunity, University College London, London, United Kingdom.
David M LoweInstitute of Immunity and Transplantation, University College London, Royal Free Campus, London, United Kingdom; Department of Clinical Immunology, Royal Free London NHS Foundation Trust, London, United Kingdom. Electronic address: d.lowe@ucl.ac.uk.
Funding
Department of Health NIHR-HCS-D12-03-15Wellcome Trust 203268/Z/16/Z
Abstract
PubMed holds no abstract for this paper.
Indexed as
Immunocompromised HostAdultAntigens, CD19Antiviral AgentsB-LymphocytesCaliciviridae InfectionsCells, CulturedCommon Variable ImmunodeficiencyEnterocolitisFemaleHumansMaleMiddle AgedNitro CompoundsNorovirusProgrammed Cell Death 1 ReceptorAntigens, CD19Antiviral AgentsnitazoxanideNitro CompoundsPDCD1 protein, humanProgrammed Cell Death 1 ReceptorRibavirinThiazoles
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.